Product development resource
Capsule Packaging and Stability: Moisture, Barrier and Pack Choice
Capsule packaging must manage the combined stability needs of the shell, fill and finished product. Bottle-versus-blister selection should follow evidence, not habit.
Short answer
A capsule package must protect a system, not just a powder. Water can move among the environment, package headspace, shell and fill; oxygen or light may matter for susceptible ingredients; and repeated opening can change exposure over the product's use period.
There is no universal best pack. Bottles can be efficient and familiar, while blisters can isolate individual units. The correct choice follows the actual formulation, shell, shelf-life target, opening pattern, manufacturing line and distribution conditions.
Evidence guide: Published evidence — supported by the linked technical source. · Development guidance — a practical decision or testing framework, not a universal specification. · Manufacturer-specific — depends on the selected site, equipment and commercial arrangement. · Product-specific validation — must be demonstrated with the actual formula, process, pack and market.
Map the stability risks first
Build a risk map before selecting a container:
| Risk | Possible consequence | Information needed |
|---|---|---|
| Moisture gain | Clumping, degradation, shell softening or sticking | Sorption behaviour and exposure |
| Moisture loss | Gelatin-shell brittleness or fill changes | Shell/fill moisture interaction |
| Oxygen | Oxidation, colour or flavour change | Ingredient sensitivity and headspace |
| Light | Photodegradation or appearance change | Wavelength sensitivity and pack opacity |
| Mechanical stress | Cracked, opened or deformed capsules | Distribution and pack movement |
HPMC and gelatin have different moisture behaviour, but neither shell is automatically stable with every fill.
Bottle and blister trade-offs
| Pack | Useful when | Questions to resolve |
|---|---|---|
| Bottle | Bulk counts, efficient packing and repeated consumer access | Closure, induction seal, headspace, desiccant, opening frequency |
| Blister | Unit separation and protection of unopened doses | Formed-web barrier, lidding, seal integrity, tooling and capsule size |
| High-barrier unit pouch | Exceptional unit protection or portability is needed | Material use, line capability, cost and pack volume |
“Blister” is not one barrier specification. PVC, coated structures, cold-form systems and lidding combinations differ materially. Likewise, a bottle's protection depends on resin, wall, closure, seal, headspace and use.
Desiccants are a design choice
A desiccant may help manage package headspace and ingress, but it is not a universal remedy. Its type, quantity, placement, capacity and compatibility must suit the package and product. Too little protection can be ineffective; inappropriate drying can also create risk for moisture-dependent components such as gelatin shells.
The desiccant, container and closure should be evaluated as one package system under relevant storage and in-use conditions.
Compatibility can be bidirectional
A hygroscopic fill may draw moisture from a gelatin shell and contribute to brittleness. A humid environment may soften shells or change fill behaviour. Reactive fill components can also affect shell performance, while the package can influence the rate at which equilibrium changes.
This is why replacing gelatin with HPMC, or adding a stronger barrier, should be treated as a hypothesis to test rather than an automatic solution.
Validate the final market pack
Stability work should use the final or justified representative formulation, shell, manufacturing process and package. Assessments may include appearance, brittleness or softness, assay, degradation products where applicable, microbiology, disintegration/dissolution, moisture, closure or seal integrity and in-use exposure.
ICH Q1A(R2) explains the purpose of stability evidence in establishing shelf life and storage conditions. Exact studies and acceptance criteria depend on the product category and jurisdictions.
A packaging brief a manufacturer can use
Provide target pack count, capsule size, shell system, fill sensitivities, target markets, shelf life, distribution conditions and desired consumer opening pattern. Ask which packaging configurations the site can run, what component MOQs apply, how desiccant is inserted, what integrity controls are used, and how the proposed pack enters stability.
Packaging decisions also affect MOQ, cost and lead time.
Sources and evidence boundaries
- U.S. Food and Drug Administration, “Current Good Manufacturing Practices for Food and Dietary Supplements.” Official guidance
- Franc, Vetchý and Fülöpová, “Commercially Available Enteric Empty Hard Capsules, Production Technology and Application,” Pharmaceuticals 15 (2022): 1398. Full text
- Stegemann et al., “Application of QbD Principles for the Evaluation of Empty Hard Capsules as an Input Parameter in Formulation Development and Manufacturing,” AAPS PharmSciTech 15 (2014): 542–549. Full text
- ICH, “Q1A(R2): Stability Testing of New Drug Substances and Products.” Official guideline
Published shell-moisture observations help frame risk. They are not permission to assign a shelf life or prescribe a package without product-specific stability and compatibility evidence.